{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:27:53Z","timestamp":1759692473344},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00210-015-1091-8","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T05:16:18Z","timestamp":1422854178000},"page":"525-530","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Meal-induced insulin sensitization is preserved after acute olanzapine administration in female Sprague-Dawley rats"],"prefix":"10.1007","volume":"388","author":[{"given":"Di\u00e1na","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Heged\u0171s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9ka","family":"S\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Szilv\u00e1ssy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barna","family":"Peitl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"1091_CR1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"DB Allison","year":"1999","unstructured":"Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686\u20131696","journal-title":"Am J Psychiatry"},{"key":"1091_CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","volume":"20","author":"M Aravagiri","year":"1999","unstructured":"Aravagiri M, Teper Y, Marder SR (1999) Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 20:369\u2013377","journal-title":"Biopharm Drug Dispos"},{"key":"1091_CR3","first-page":"121","volume":"152","author":"AA Arjona","year":"2004","unstructured":"Arjona AA, Zhang SX, Adamson B, Wurtman RJ (2004) An animal model of antipsychotic-induced weight gain. Behav Brain Res 152:121\u2013127","journal-title":"Behav Brain Res"},{"key":"1091_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4088\/JCP.v62n0404","volume":"62","author":"BR Basson","year":"2001","unstructured":"Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD (2001) Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62:231\u2013238","journal-title":"J Clin Psychiatry"},{"key":"1091_CR5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1124\/jpet.110.166892","volume":"334","author":"L Chen","year":"2010","unstructured":"Chen L, McNulty J, Anderson D, Liu Y, Nystrom C, Bullard S, Collins J, Handlon AL, Klein R, Grimes A, Murray D, Brown R, Krull D, Benson B, Kleymenova E, Remlinger K, Young A, Yao X (2010) Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats. J Pharmacol Exp Ther 334:164\u2013170","journal-title":"J Pharmacol Exp Ther"},{"key":"1091_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2008.06.006","volume":"104","author":"AF Chintoh","year":"2008","unstructured":"Chintoh AF, Mann SW, Lam TK, Giacca A, Remington G (2008) Insulin resistance following continuous, chronic olanzapine treatment: an animal model. Schizophr Res 104:23\u201330","journal-title":"Schizophr Res"},{"key":"1091_CR7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.lfs.2007.08.009","volume":"81","author":"S Choi","year":"2007","unstructured":"Choi S, DiSilvio B, Unangst J, Fernstrom JD (2007) Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats. Life Sci 81:1024\u20131030","journal-title":"Life Sci"},{"key":"1091_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00213-005-2224-4","volume":"181","author":"GD Cooper","year":"2005","unstructured":"Cooper GD, Pickavance LC, Wilding JP, Halford JC, Goudie AJ (2005) A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl) 181:80\u201389","journal-title":"Psychopharmacology (Berl)"},{"key":"1091_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1034\/j.1399-5448.2003.t01-1-00022.x","volume":"4","author":"WS Cutfield","year":"2003","unstructured":"Cutfield WS, Jefferies CA, Jackson WE, Robinson EM, Hofman PL (2003) Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr Diabetes 4:119\u2013125","journal-title":"Pediatr Diabetes"},{"key":"1091_CR10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2011.06.004","volume":"131","author":"M Hahn","year":"2011","unstructured":"Hahn M, Chintoh A, Giacca A, Xu L, Lam L, Mann S, Fletcher P, Guenette M, Cohn T, Wolever T, Arenovich T, Remington G (2011) Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model. Schizophr Res 131:90\u201395","journal-title":"Schizophr Res"},{"key":"1091_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","volume":"62","author":"DC Henderson","year":"2005","unstructured":"Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC (2005) Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 62:19\u201328","journal-title":"Arch Gen Psychiatry"},{"key":"1091_CR12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","volume":"157","author":"DC Henderson","year":"2000","unstructured":"Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC (2000) Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 157:975\u2013981","journal-title":"Am J Psychiatry"},{"key":"1091_CR13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejphar.2007.04.043","volume":"568","author":"L Herczeg","year":"2007","unstructured":"Herczeg L, Buherenkova T, Szilvassy Z, Peitl B (2007) Diabetes induced by partial hepatic sensory denervation in conscious rabbits. Eur J Pharmacol 568:287\u2013288","journal-title":"Eur J Pharmacol"},{"key":"1091_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.npp.1301209","volume":"32","author":"KL Houseknecht","year":"2007","unstructured":"Houseknecht KL, Robertson AS, Zavadoski W, Gibbs EM, Johnson DE, Rollema H (2007) Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects. Neuropsychopharmacology 32:289\u2013297","journal-title":"Neuropsychopharmacology"},{"key":"1091_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1566-0702(01)00390-3","volume":"95","author":"MG Latour","year":"2002","unstructured":"Latour MG, Lautt WW (2002) The hepatic vagus nerve in the control of insulin sensitivity in the rat. Auton Neurosci 95:125\u2013130","journal-title":"Auton Neurosci"},{"key":"1091_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1139\/y99-067","volume":"77","author":"WW Lautt","year":"1999","unstructured":"Lautt WW (1999) The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can J Physiol Pharmacol 77:553\u2013562","journal-title":"Can J Physiol Pharmacol"},{"key":"1091_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1254\/jphs.95.9","volume":"95","author":"WW Lautt","year":"2004","unstructured":"Lautt WW (2004) A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis. J Pharmacol Sci 95:9\u201317","journal-title":"J Pharmacol Sci"},{"key":"1091_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1139\/Y11-001","volume":"89","author":"WW Lautt","year":"2011","unstructured":"Lautt WW, Schafer J, Macedo MP, Legare DJ (2011) Bethanechol and N-acetylcysteine mimic feeding signals and reverse insulin resistance in fasted and sucrose-induced diabetic rats. Can J Physiol Pharmacol 89:135\u2013142","journal-title":"Can J Physiol Pharmacol"},{"key":"1091_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0091-3057(01)00630-X","volume":"71","author":"MD Lee","year":"2002","unstructured":"Lee MD, Clifton PG (2002) Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol. Pharmacol Biochem Behav 71:147\u2013154","journal-title":"Pharmacol Biochem Behav"},{"key":"1091_CR20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2133\/dmpk.20.368","volume":"20","author":"A Matsui-Sakata","year":"2005","unstructured":"Matsui-Sakata A, Ohtani H, Sawada Y (2005) Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet 20:368\u2013378","journal-title":"Drug Metab Pharmacokinet"},{"key":"1091_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"1091_CR22","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19(Suppl 1):1\u201393","journal-title":"CNS Drugs"},{"key":"1091_CR23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.59.4.337","volume":"59","author":"JW Newcomer","year":"2002","unstructured":"Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweiger JA, Cooper BP, Selke G (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 59:337\u2013345","journal-title":"Arch Gen Psychiatry"},{"key":"1091_CR24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.metabol.2004.11.014","volume":"54","author":"B Peitl","year":"2005","unstructured":"Peitl B, Dobronte R, Nemeth J, Mezey G, Kovacs P, Paragh G, Szilvassy Z (2005) The prandial insulin sensitivity-modifying effect of vagal stimulation in rats. Metabolism 54:579\u2013583","journal-title":"Metabolism"},{"key":"1091_CR25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.metabol.2008.10.004","volume":"58","author":"B Peitl","year":"2009","unstructured":"Peitl B, Dobronte R, Nemeth J, Pankucsi C, Sari R, Varga A, Szilvassy Z (2009) Meal-induced enhancement in insulin sensitivity is not triggered by hyperinsulinemia in rats. Metabolism 58:328\u2013332","journal-title":"Metabolism"},{"key":"1091_CR26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.metabol.2007.03.004","volume":"56","author":"B Peitl","year":"2007","unstructured":"Peitl B, Szilvassy Z (2007) The inhibitory effect of proglumide on meal-induced insulin sensitization in rats. Metabolism 56:863\u2013864","journal-title":"Metabolism"},{"key":"1091_CR27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.bjp.0705342","volume":"139","author":"R Porszasz","year":"2003","unstructured":"Porszasz R, Legvari G, Pataki T, Szilvassy J, Nemeth J, Kovacs P, Paragh G, Szolcsanyi J, Szilvassy Z (2003) Hepatic insulin sensitizing substance: a novel 'sensocrine' mechanism to increase insulin sensitivity in anaesthetized rats. Br J Pharmacol 139:1171\u20131179","journal-title":"Br J Pharmacol"},{"key":"1091_CR28","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1210\/jcem.86.10.7952","volume":"86","author":"MJ Quon","year":"2001","unstructured":"Quon MJ (2001) Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab 86:4615\u20134617","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","volume":"123","author":"C Rummel-Kluge","year":"2010","unstructured":"Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, Kissling W, Davis JM, Leucht S (2010) Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 123:225\u2013233","journal-title":"Schizophr Res"},{"key":"1091_CR30","first-page":"19","volume":"40","author":"P Sadri","year":"1997","unstructured":"Sadri P, Legare DJ, Lautt WW (1997) Insulin resistance caused by nitric oxide synthase inhibition. Proc West Pharmacol Soc 40:19\u201320","journal-title":"Proc West Pharmacol Soc"},{"key":"1091_CR31","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.2337\/db13-0430","volume":"62","author":"KL Teff","year":"2013","unstructured":"Teff KL, Rickels MR, Grudziak J, Fuller C, Nguyen HL, Rickels K (2013) Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease. Diabetes 62:3232\u20133240","journal-title":"Diabetes"},{"key":"1091_CR32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ijo.2011.97","volume":"36","author":"EM Zwaal van der","year":"2012","unstructured":"van der Zwaal EM, Merkestein M, Lam YK, Brans MA, Luijendijk MC, Bok LI, Verheij ER, la Fleur SE, Adan RA (2012) The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature. Int J Obes 36:254\u2013261","journal-title":"Int J Obes"},{"key":"1091_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-09-0433","volume":"162","author":"S Vidarsdottir","year":"2010","unstructured":"Vidarsdottir S, Roelfsema F, Streefland T, Holst JJ, Rehfeld JF, Pijl H (2010) Short-term treatment with olanzapine does not modulate gut hormone secretion: olanzapine disintegrating versus standard tablets. Eur J Endocrinol \/ Eur Fed Endocr Soc 162:75\u201383","journal-title":"Eur J Endocrinol \/ Eur Fed Endocr Soc"},{"key":"1091_CR34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1464-5491.2002.00745.x","volume":"19","author":"TM Wallace","year":"2002","unstructured":"Wallace TM, Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med 19:527\u2013534","journal-title":"Diabet Med"},{"key":"1091_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.47.1.1","volume":"47","author":"S Wallenstein","year":"1980","unstructured":"Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1\u20139","journal-title":"Circ Res"},{"key":"1091_CR36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","volume":"217","author":"K Weston-Green","year":"2011","unstructured":"Weston-Green K, Huang XF, Deng C (2011) Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats. Behav Brain Res 217:337\u2013346","journal-title":"Behav Brain Res"},{"key":"1091_CR37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40263-013-0115-5","volume":"27","author":"K Weston-Green","year":"2013","unstructured":"Weston-Green K, Huang XF, Deng C (2013) Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic m3 receptor. CNS Drugs 27:1069\u20131080","journal-title":"CNS Drugs"},{"key":"1091_CR38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.euroneuro.2011.09.003","volume":"22","author":"K Weston-Green","year":"2012","unstructured":"Weston-Green K, Huang XF, Lian J, Deng C (2012) Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels. Eur Neuropsychopharmacol : J Eur Coll Neuropsychopharmacol 22:364\u2013373","journal-title":"Eur Neuropsychopharmacol : J Eur Coll Neuropsychopharmacol"},{"key":"1091_CR39","first-page":"39","volume":"37","author":"H Xie","year":"1994","unstructured":"Xie H, Lautt WW (1994) Insulin resistance produced by hepatic denervation or muscarinic cholinergic blockade. Proc West Pharmacol Soc 37:39\u201340","journal-title":"Proc West Pharmacol Soc"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-015-1091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-015-1091-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-015-1091-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T13:19:36Z","timestamp":1690982376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-015-1091-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1007\/s00210-015-1091-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}